Ogiso T, Niinaka N, Iwaki M
Faculty of Pharmaceutical Sciences, Kinki University, Kowakae, Osaka, Japan.
J Pharm Sci. 1996 Jan;85(1):57-64. doi: 10.1021/js950178x.
To clarify the mechanism involved in the enhancement effect of lipid disperse systems (LDS) on percutaneous absorption, the effect of the LDSs of betahistine (BH), prepared using egg phosphatidylcholine (EPC, phase transition temperature, tau m, -15 to -17 degrees C) or hydrogenated soybean phosphatidylcholine (HSPC, tau m, 50 to 60 degrees C), cholesterol, and dicetylphosphate, on the percutaneous absorption of BH, the amount of skin lipids (ceramides, triglycerides, and phospholipids), the fluidity of skin lipids, and the partitioning of LDS-BH into the skin layers were investigated using Wistar and hairless rats. Also examined was whether the LDS penetrated through the stratum corneum (SC) or follicles, using a fluorescent probe (Nile Red). The plasma concentrations of BH were much higher and more sustained after application of a gel formulation containing EPC-LDS and D-limonene (prep. 2) than those after the non-LDS formulation containing D-limonene (prep. 1), whereas the plasma levels after application of a formulation containing HSPC-LDS (prep. 5) were not largely increased compared with those after prep. 1. The content of ceramides (intercellular lipids) and triglycerides (sebaceous gland lipides) in the SC were dramatically decreased by the treatment with prep. 1 and prep. 2, with the more decreased levels of these lipids by the treatment with prep. 2. The phospholipid content of the SC was enhanced by 2-fold following the prep. 2 treatment, indicating the extensive incorporation of LDS lipids into the SC. The histochemical examination of the skin, following application of EPC-LDS with a fluorescent probe, indicated that the LDS lipids penetrated rapidly through the SC and follicles into the viable skins. The fluidity of the SC lipids was dramatically increased following the treatment with the fluid EPC-LDS, whereas the fluidity was significantly decreased by the solid HSPC-LDS. The BH in each skin layer was also significantly increased by the treatment with prep. 2. These results surely demonstrated that the fluid LDS permeated rapidly into the SC and the viable epidermis through the intercellular domains and the follicles in intact vesicles or lipid mixtures, thus ensuring the facilitated transport of LDS-drug through the skin.
为阐明脂质分散系统(LDS)对经皮吸收增强作用的机制,使用Wistar大鼠和无毛大鼠研究了用鸡蛋磷脂酰胆碱(EPC,相变温度τm为-15至-17℃)或氢化大豆磷脂酰胆碱(HSPC,τm为50至60℃)、胆固醇和二鲸蜡基磷酸酯制备的倍他司汀(BH)的LDS对BH经皮吸收、皮肤脂质(神经酰胺、甘油三酯和磷脂)含量、皮肤脂质流动性以及LDS-BH在皮肤各层中的分配情况的影响。还使用荧光探针(尼罗红)检测了LDS是否通过角质层(SC)或毛囊渗透。与含D-柠檬烯的非LDS制剂(制剂1)相比,应用含EPC-LDS和D-柠檬烯的凝胶制剂(制剂2)后,BH的血浆浓度更高且更持久,而应用含HSPC-LDS的制剂(制剂5)后的血浆水平与制剂1相比没有大幅升高。制剂1和制剂2处理后,SC中神经酰胺(细胞间脂质)和甘油三酯(皮脂腺脂质)的含量显著降低,制剂2处理后这些脂质的降低水平更高。制剂2处理后,SC的磷脂含量增加了2倍,表明LDS脂质大量掺入SC。用荧光探针应用EPC-LDS后对皮肤进行组织化学检查表明,LDS脂质迅速通过SC和毛囊进入有活力的皮肤。用流动性好的EPC-LDS处理后,SC脂质的流动性显著增加,而用固态HSPC-LDS处理后流动性显著降低。制剂2处理后,各皮肤层中的BH也显著增加。这些结果确实表明,流动性好的LDS通过完整囊泡或脂质混合物中的细胞间区域和毛囊迅速渗透到SC和有活力的表皮中,从而确保LDS-药物通过皮肤的促进转运。